116 related articles for article (PubMed ID: 38164862)
1. IL-17A as a new circulating bioindicator for non-small cell lung cancer diagnosis and prognosis.
Wang JX; Xu XJ; Zhu ZM; Cao WL; Yang ZP; Zhen JL; Wu YY; Lu FM; Liu SW
Eur Rev Med Pharmacol Sci; 2023 Dec; 27(24):12004-12011. PubMed ID: 38164862
[TBL] [Abstract][Full Text] [Related]
2. Serum CCL20 combined with IL-17A as early diagnostic and prognostic biomarkers for human colorectal cancer.
Wang D; Yuan W; Wang Y; Wu Q; Yang L; Li F; Chen X; Zhang Z; Yu W; Maimela NR; Cao L; Wang D; Wang J; Sun Z; Liu J; Zhang Y
J Transl Med; 2019 Aug; 17(1):253. PubMed ID: 31387598
[TBL] [Abstract][Full Text] [Related]
3. IL-17A/IL-17RA promotes invasion and activates MMP-2 and MMP-9 expression via p38 MAPK signaling pathway in non-small cell lung cancer.
Wu Z; He D; Zhao S; Wang H
Mol Cell Biochem; 2019 May; 455(1-2):195-206. PubMed ID: 30564960
[TBL] [Abstract][Full Text] [Related]
4. Circulating TP73-AS1 and CRNDE serve as diagnostic and prognostic biomarkers for non-small cell lung cancer.
Yuan RX; Dai CH; Chen P; Lv MJ; Shu Y; Wang ZP; Xu YP; Li J
Cancer Med; 2023 Jan; 12(2):1655-1672. PubMed ID: 35871358
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic and prognostic value of serum thioredoxin and DJ-1 in non-small cell lung carcinoma patients.
Fan J; Yu H; Lv Y; Yin L
Tumour Biol; 2016 Feb; 37(2):1949-58. PubMed ID: 26334622
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the relationship between the IL-17A gene expression level and regulatory miRNA-9 in relation to tumor progression in patients with non-small cell lung cancer: a pilot study.
Migdalska-Sęk M; Góralska K; Jabłoński S; Kordiak J; Nawrot E; Kiszałkiewicz JM; Pastuszak-Lewandoska D; Baran K; Stuss M; Brzeziańska-Lasota E
Mol Biol Rep; 2020 Jan; 47(1):583-592. PubMed ID: 31707599
[TBL] [Abstract][Full Text] [Related]
7. Expression of IL-17A, E, and F and their receptors in non-small-cell lung cancer.
Huang Q; Ma XC; Yang X; Wang W; Li Y; Lv Z; Corrigan CJ; Chen Y; Ying S
J Biol Regul Homeost Agents; 2018; 32(5):1105-1116. PubMed ID: 30334403
[TBL] [Abstract][Full Text] [Related]
8. Circulating long noncoding RNA act as potential novel biomarkers for diagnosis and prognosis of non-small cell lung cancer.
Xie Y; Zhang Y; Du L; Jiang X; Yan S; Duan W; Li J; Zhan Y; Wang L; Zhang S; Li S; Wang L; Xu S; Wang C
Mol Oncol; 2018 May; 12(5):648-658. PubMed ID: 29504701
[TBL] [Abstract][Full Text] [Related]
9. Identification of Circulating miR-762 as a Novel Diagnostic and Prognostic Biomarker for Non-Small Cell Lung Cancer.
Chen L; Li Y; Lu J
Technol Cancer Res Treat; 2020; 19():1533033820964222. PubMed ID: 33317398
[TBL] [Abstract][Full Text] [Related]
10. Clinical Value of Serum and Exhaled Breath Condensate miR-186 and IL-1β Levels in Non-Small Cell Lung Cancer.
Xie H; Chen J; Lv X; Zhang L; Wu J; Ge X; Yang Q; Zhang D; Chen J
Technol Cancer Res Treat; 2020; 19():1533033820947490. PubMed ID: 32851926
[TBL] [Abstract][Full Text] [Related]
11. Interleukin 8 in plasma is an efficacy marker for advanced non-small cell lung cancer treated with hypofractionated radiotherapy and PD-1 blockade.
Kang P; Liu D; Li L; Guo X; Ye Y; Li Y; Jiang Q; Lin S; Yuan Q
Cytokine; 2023 Mar; 163():156133. PubMed ID: 36724715
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic and prognostic values of endothelial-cell-specific molecule-1 with malignant pleural effusions in patients with non-small cell lung cancer.
Lu GJ; Shao CJ; Zhang Y; Wei YY; Xie WP; Kong H
Oncotarget; 2017 Jul; 8(30):49217-49223. PubMed ID: 28514746
[TBL] [Abstract][Full Text] [Related]
13. Low plasma miR-25 expression is a favorite prognosis factor in non-small cell lung cancer.
Zhang YL; Zhang ZL; Zhu XB; Xu L; Lu P; Xu M; Liu WJ; Zhang XY; Yao HM; Ye XW
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5251-5259. PubMed ID: 31298376
[TBL] [Abstract][Full Text] [Related]
14. Serum miR-185 Is a Diagnostic and Prognostic Biomarker for Non-Small Cell Lung Cancer.
Liu J; Han Y; Liu X; Wei S
Technol Cancer Res Treat; 2020; 19():1533033820973276. PubMed ID: 33251978
[TBL] [Abstract][Full Text] [Related]
15. [Clinical value of tumor-associated autoantibodies in diagnosis of early non-small cell lung cancer].
Ren Z; Ding HM; Qian X; Pan SY
Zhonghua Yu Fang Yi Xue Za Zhi; 2021 Dec; 55(12):1426-1434. PubMed ID: 34963239
[No Abstract] [Full Text] [Related]
16. Potential Impacts of
Lee KL; Lai TC; Wang YC; Shih PC; Yang YC; Tsao TC; Liu TC; Wen YC; Chang LC; Yang SF; Chien MH
Genes (Basel); 2021 Mar; 12(3):. PubMed ID: 33802737
[TBL] [Abstract][Full Text] [Related]
17. A promising role of interferon regulatory factor 5 as an early warning biomarker for the development of human non-small cell lung cancer.
Guo J; Wang X; Wang Y; Wang L; Hua S
Lung Cancer; 2019 Sep; 135():47-55. PubMed ID: 31447002
[TBL] [Abstract][Full Text] [Related]
18. Identification of GlcNAcylated alpha-1-antichymotrypsin as an early biomarker in human non-small-cell lung cancer by quantitative proteomic analysis with two lectins.
Jin Y; Wang J; Ye X; Su Y; Yu G; Yang Q; Liu W; Yu W; Cai J; Chen X; Liang Y; Chen Y; Wong BH; Fu X; Sun H
Br J Cancer; 2016 Mar; 114(5):532-44. PubMed ID: 26908325
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-340 and MicroRNA-450b-5p: Plasma Biomarkers for Detection of Non-Small-Cell Lung Cancer.
Wu Y; Jing H; Zhang J
J Environ Public Health; 2022; 2022():8024700. PubMed ID: 36531335
[TBL] [Abstract][Full Text] [Related]
20. Folate Receptor-Positive Circulating Tumor Cell Detected by LT-PCR-Based Method as a Diagnostic Biomarker for Non-Small-Cell Lung Cancer.
Chen X; Zhou F; Li X; Yang G; Zhang L; Ren S; Zhao C; Deng Q; Li W; Gao G; Li A; Zhou C
J Thorac Oncol; 2015 Aug; 10(8):1163-71. PubMed ID: 26200270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]